Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021

SELL
$232.65 - $254.58 $264,755 - $289,712
-1,138 Closed
0 $0
Q1 2021

May 05, 2021

SELL
$232.09 - $256.88 $1.62 Million - $1.8 Million
-6,997 Reduced 86.01%
1,138 $262,000
Q4 2020

Feb 11, 2021

BUY
$221.92 - $245.94 $29,959 - $33,201
135 Added 1.69%
8,135 $2.04 Million
Q3 2020

Nov 12, 2020

SELL
$215.77 - $276.76 $180,815 - $231,924
-838 Reduced 9.48%
8,000 $1.86 Million
Q2 2020

Aug 14, 2020

SELL
$219.9 - $263.41 $65,970 - $79,023
-300 Reduced 3.28%
8,838 $2.11 Million
Q1 2020

May 14, 2020

BUY
$195.69 - $279.01 $1.61 Million - $2.3 Million
8,248 Added 926.74%
9,138 $2.1 Million
Q4 2019

Feb 12, 2020

BUY
$236.45 - $266.82 $2,600 - $2,935
11 Added 1.25%
890 $242,000
Q3 2019

Nov 14, 2019

BUY
$230.58 - $256.08 $202,679 - $225,094
879 New
879 $222,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $68.8B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Associated Banc Corp Portfolio

Follow Associated Banc Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Associated Banc Corp, based on Form 13F filings with the SEC.

News

Stay updated on Associated Banc Corp with notifications on news.